A detailed history of Roberts Glore & CO Inc transactions in Medtronic PLC stock. As of the latest transaction made, Roberts Glore & CO Inc holds 7,562 shares of MDT stock, worth $610,555. This represents 0.2% of its overall portfolio holdings.

Number of Shares
7,562
Previous 7,737 2.26%
Holding current value
$610,555
Previous $608,000 11.84%
% of portfolio
0.2%
Previous 0.19%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$76.84 - $91.03 $13,447 - $15,930
-175 Reduced 2.26%
7,562 $680,000
Q2 2024

Aug 14, 2024

SELL
$78.71 - $87.02 $10,311 - $11,399
-131 Reduced 1.66%
7,737 $608,000
Q1 2024

May 09, 2024

SELL
$82.84 - $88.09 $18,224 - $19,379
-220 Reduced 2.72%
7,868 $685,000
Q4 2023

Feb 12, 2024

SELL
$69.43 - $83.43 $44,574 - $53,562
-642 Reduced 7.35%
8,088 $666,000
Q3 2023

Nov 13, 2023

SELL
$78.22 - $90.4 $35,199 - $40,680
-450 Reduced 4.9%
8,730 $684,000
Q2 2023

Aug 14, 2023

SELL
$79.47 - $91.38 $9,933 - $11,422
-125 Reduced 1.34%
9,180 $808,000
Q1 2023

May 08, 2023

SELL
$76.72 - $87.58 $9,973 - $11,385
-130 Reduced 1.38%
9,305 $750,000
Q4 2022

Feb 13, 2023

SELL
$76.18 - $87.74 $2,971 - $3,421
-39 Reduced 0.41%
9,435 $733,000
Q3 2022

Nov 07, 2022

SELL
$80.75 - $95.31 $16,553 - $19,538
-205 Reduced 2.12%
9,474 $765,000
Q2 2022

Aug 11, 2022

SELL
$87.4 - $113.09 $4,370 - $5,654
-50 Reduced 0.51%
9,679 $869,000
Q1 2022

May 02, 2022

SELL
$100.58 - $112.38 $1,005 - $1,123
-10 Reduced 0.1%
9,729 $1.08 Million
Q4 2021

Feb 11, 2022

BUY
$99.53 - $127.75 $497 - $638
5 Added 0.05%
9,739 $1.01 Million
Q3 2021

Nov 12, 2021

BUY
$122.75 - $135.17 $49,100 - $54,067
400 Added 4.29%
9,734 $1.22 Million
Q2 2021

Aug 10, 2021

SELL
$118.19 - $131.5 $709 - $789
-6 Reduced 0.06%
9,334 $1.16 Million
Q1 2021

May 06, 2021

SELL
$111.18 - $119.74 $19,456 - $20,954
-175 Reduced 1.84%
9,340 $1.1 Million
Q3 2020

Nov 06, 2020

BUY
$90.13 - $108.78 $13,249 - $15,990
147 Added 1.57%
9,515 $988,000
Q2 2020

Aug 13, 2020

SELL
$84.11 - $103.33 $24,223 - $29,759
-288 Reduced 2.98%
9,368 $859,000
Q1 2020

May 11, 2020

BUY
$72.92 - $121.3 $2,552 - $4,245
35 Added 0.36%
9,656 $870,000
Q4 2019

Feb 13, 2020

BUY
$104.49 - $114.54 $290,586 - $318,535
2,781 Added 40.66%
9,621 $1.09 Million
Q3 2019

Nov 08, 2019

BUY
$98.02 - $111.18 $58,517 - $66,374
597 Added 9.56%
6,840 $743,000
Q4 2018

Feb 08, 2019

SELL
$85.8 - $99.49 $42,900 - $49,745
-500 Reduced 7.42%
6,243 $568,000
Q2 2018

Aug 10, 2018

SELL
$77.48 - $87.83 $31,766 - $36,010
-410 Reduced 5.73%
6,743 $577,000
Q4 2017

Feb 09, 2018

SELL
$76.93 - $83.5 $16,924 - $18,370
-220 Reduced 2.98%
7,153 $578,000
Q3 2017

Nov 08, 2017

SELL
$77.71 - $84.6 $19,816 - $21,573
-255 Reduced 3.34%
7,373 $573,000
Q2 2017

Aug 15, 2017

BUY
N/A
7,628
7,628 $677,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $107B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Roberts Glore & CO Inc Portfolio

Follow Roberts Glore & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.